Tiziana life sciences ltd reports annual results for the twelve months ended december 31, 2022, and corporate update

New york, april 26, 2023 (globe newswire) -- tiziana life sciences, ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced financial results for the twelve months ended december 31, 2022, and provided a corporate update on its lead programs in development.
TLSA Ratings Summary
TLSA Quant Ranking